CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 40 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2016. The put-call ratio across all filers is 1.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,420,000 | -76.0% | 200,000 | -75.9% | 0.05% | -58.4% |
| Q3 2017 | $5,928,000 | -23.6% | 829,368 | -32.7% | 0.11% | -71.1% |
| Q2 2017 | $7,764,000 | -24.7% | 1,232,500 | -1.4% | 0.39% | -33.4% |
| Q1 2017 | $10,312,000 | -2.4% | 1,250,000 | -0.1% | 0.59% | -21.8% |
| Q4 2016 | $10,562,000 | -42.4% | 1,251,600 | -53.7% | 0.75% | -36.6% |
| Q3 2016 | $18,339,000 | +91.7% | 2,701,023 | -15.6% | 1.18% | +78.6% |
| Q2 2016 | $9,568,000 | +323.0% | 3,200,000 | +156.0% | 0.66% | +234.8% |
| Q1 2016 | $2,262,000 | +9.7% | 1,250,000 | 0.0% | 0.20% | +29.4% |
| Q4 2015 | $2,062,000 | -47.5% | 1,250,000 | -50.0% | 0.15% | -2.5% |
| Q3 2015 | $3,924,000 | +46.5% | 2,500,000 | +187.4% | 0.16% | -2.5% |
| Q2 2015 | $2,679,000 | – | 870,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,985,870 | $34,552,000 | 28.29% |
| ETF MANAGERS GROUP, LLC | 7,011,051 | $48,587,000 | 1.55% |
| DAFNA Capital Management LLC | 297,300 | $2,060,000 | 0.77% |
| GENERAL AMERICAN INVESTORS CO INC | 557,400 | $3,863,000 | 0.37% |
| Aries Wealth Management | 27,400 | $187,000 | 0.13% |
| WOODSTOCK CORP | 57,213 | $396,000 | 0.07% |
| Virtus ETF Advisers LLC | 38,935 | $270,000 | 0.06% |
| Mirae Asset Global Investments Co., Ltd. | 1,075,170 | $7,451,000 | 0.05% |
| EXANE DERIVATIVES | 35,502 | $245,934,000 | 0.04% |
| ELLINGTON MANAGEMENT GROUP LLC | 24,100 | $167,000 | 0.03% |